Scientists have documented the world’s first case of simultaneous infection with COVID-19, monkeypox and HIV, the medical journal Journal of Infection reported on August 19.
The patient turned out to be a 36-year-old Italian who spent time from June 16 to 20, 2022 in Spain and then felt unwell. His temperature rose to 39°C, his throat hurt. He went to an Italian hospital in the city of Catania, where he was transferred to the Department of Infectious Diseases.
First, he passed a positive test for coronavirus infection. Later, he developed a rash, ulcerative formations spread throughout the body. As a result of the tests, doctors diagnosed him with HIV and monkeypox.
It is noted that the patient, while previously in Spain, had unprotected sexual contact.
“Our case indicates that sexual intercourse may be the predominant mode of transmission. Therefore, full screening for sexually transmitted infections is recommended after a diagnosis of monkeypox is made.
On July 23, the World Health Organization (WHO) declared the spread of monkeypox a global emergency. On August 17, the head of WHO, Tedros Adhanom Ghebreyesus, said that 35 thousand cases of the disease were registered in 92 countries of the world, 12 people died.
Virologist Anatoly Altshtein said on July 18 that the monkeypox virus could not spread as widely as the coronavirus due to its low infectivity. He clarified that, unlike COVID-19, which is transmitted by airborne droplets, the causative agent of monkeypox can infect a person only through close contact with the patient.
On July 28, it became known that, according to WHO, the incidence of coronavirus in Europe and Africa is declining, in Asia it is growing. On August 15, in an interview with Izvestia, Sergey Netesov, head of the laboratory of bionanotechnology, microbiology and virology at Novosibirsk State University, Academician of the Russian Academy of Sciences, predicted that the incidence of COVID-19 in Russia should decline in the next two weeks.